AIP

Arteris, Inc. (AIP) - Q1 2026 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2026. Arteris, Inc. is a leading provider of semiconductor system IP, including interconnect and Network-on-Chip (NoC) technology, as well as SoC integration automation and hardware security verification software. The company operates as a single reporting segment with a global footprint including offices in the U.S., Europe, and Asia. A significant event during the period was the acquisition of Cycuity, Inc. on January 14, 2026, to enhance hardware security capabilities.

Key Financial Metrics

Note: Cash and investments total includes $11.7 million in cash equivalents, $26.4 million in short-term investments, and $3.8 million in long-term investments as of March 31, 2026.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 39% year-over-year, driven by a 26% increase in licensing/support revenue and a 114% surge in variable royalties. Professional services revenue grew significantly due to new U.S. government contracts acquired via Cycuity.
• Expense Increases: Operating expenses rose 28% to $29.0 million. R&D expenses increased 22% due to headcount growth and next-generation product investments. Sales and marketing expenses rose 31% to support business growth.
• Acquisition Impact: The Cycuity acquisition resulted in $0.6 million in acquisition-related costs and added $31.0 million in goodwill and $18.1 million in intangible assets to the balance sheet.
• Equity Method Loss: Loss from the equity method investment in Transchip increased to $3.0 million (from $0.8 million), primarily due to the company's share of Transchip's stock-based compensation expense.
• Tax Benefit: The company recorded a $3.7 million income tax benefit, reversing a $0.3 million expense in the prior year, largely due to a partial valuation allowance release associated with the Cycuity acquisition.

Outlook, Risks, and Management Commentary

• Liquidity: Management believes existing cash, cash equivalents, and investments ($41.9 million) are sufficient to meet working capital needs for at least the next 12 months. The company utilized its At-The-Market (ATM) offering program to raise $0.5 million in net proceeds during the quarter.
• Key Performance Indicators: Annual Contract Value (ACV) reached $84.9 million (up from $62.1 million in Q1 2025). Confirmed Design Starts totaled 25 for the quarter.
• Risks: Significant risks include geopolitical tensions affecting operations in China (23.8% of revenue), U.S. export controls on advanced semiconductors, and the cyclical nature of the semiconductor industry. The company faces ongoing litigation regarding intellectual property claims from Network System Technologies, LLC (NST), though claims against Arteris were previously dismissed without prejudice.
• Guidance: The filing does not provide specific forward-looking financial guidance for the full year 2026 beyond the statement that operating results for the quarter are not necessarily indicative of future results.

Investor Verification Checklist

• Acquisition Integration: Verify the progress of integrating Cycuity's hardware security technology and the realization of anticipated synergies.
• China Exposure: Monitor the impact of U.S. export controls and geopolitical tensions on the 23.8% of revenue derived from China.
• Equity Method Investment: Review the status of the Transchip investment, which currently has no carrying value, and the sustainability of the losses recognized.
• Government Contracts: Assess the stability and renewal prospects of the new U.S. government contracts contributing to professional services revenue.
• Cash Burn: Track the trajectory of operating cash flow, which turned negative ($7.1 million outflow) compared to the prior year's positive flow, driven by the acquisition and working capital changes.